載入...
克唑替尼治疗ALK阳性晚期非小细胞肺癌患者的疗效观察
BACKGROUND AND OBJECTIVE: The aim of this study is to explore clinical efficacy of crizotinib in advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer. METHODS: Twenty-eight patients with advanced non-small cell lung cancer habouring ALK positive were randomly divided into cr...
Na minha lista:
| 發表在: | Zhongguo Fei Ai Za Zhi |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
中国肺癌杂志编辑部
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000091/ https://ncbi.nlm.nih.gov/pubmed/26483333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|